KK

Active Director Director DIN 07500052
DIN 07500052 First appointment May 2016 Primary industry Education
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value •••• Premium profile

About Komal Kag

Data last updated:

Komal Kag is a Director at Ribosome Institute Private Limited (since 2016). The company operates in Education. Ribosome Institute Private Limited reported revenue of ₹6.13 Cr (FY 2024).

DIN 07500052
Primary Designation Director
Industry Education
First Appointment 25 May 2016
Oldest Company Age 10 yrs
Largest company Ribosome Institute Private Limited · ₹6.13 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ribosome Institute Private Limited U74999MP2016PTC040823
Director25 May 20162016₹6.13 Cr (FY 2024)Active

Board colleagues of Komal Kag

NameDINCompanyDesignation
Sudhir Kag07500019Ribosome Institute Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ribosome Institute Private Limited
Premium access

Shareholding and investment profile for Komal Kag

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Komal Kag

Komal Kag currently holds 1 directorship: Ribosome Institute Private Limited (Director, since 25 May 2016, revenue ₹6.13 Cr (FY 2024)).

Komal Kag was first appointed on 25 May 2016 as Director at Ribosome Institute Private Limited.

The current boards of Komal Kag's companies include Sudhir Kag (Ribosome Institute Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available